Intro Pullout Text Widget

Open Heart

is an open access journal by BMJ and BCS, publishing original research in cardiovascular medicine.

Open Heart is dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Research is published across all study phases and designs, from protocols to phase I trials to meta-analyses, including small or specialist studies. Opinionated discussions on controversial topics are welcomed.

Open Heart is an official journal of the British Cardiovascular Society.

Follow the journal via Twitter and Facebook.

Editor-in-Chief: Dr Pascal Meier, Hospital of Graubunden (Switzerland) and Royal Brompton Hospital (UK)
Editorial team

BCS COVID-19 resource hub >>

Current Issue

Authors

Open Heart considers submissions of a variety of article types, including original research articles, study protocols and occasional review articles. Responses to published work are also welcomed.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Author information

Submit a paper

Twitter Feed

Open Heart ·
@Open_HeartBMJ

Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire https://t.co/kk6sb98Cwq https://t.co/Fs4UwscCiC

View on Twitter

Open Heart ·
@Open_HeartBMJ

FLOWER-MI & root of the problem with non-culprit revascularisation

@mattlkw @K_DeSilva @ColletCarlos @divaka_perera
#OpenHeartBMJ #FLOWERMI
https://t.co/E6UAWsrtrx https://t.co/mtxc6d8PVd

View on Twitter

Open Heart ·
@Open_HeartBMJ

CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation: https://t.co/mfHCM0OeYx https://t.co/n157ZDu1eC

View on Twitter

Open Heart ·
@Open_HeartBMJ

What’s the role of Vitamin K2 in CV health?

Read this review by @EssaHariri @AbdelfattahMD @tavrkapadia @AnasSaad94 @SergeHarbMD

#OpenHeartBMJ
https://t.co/1laRwCSK9k https://t.co/3GH7t5dSfW

View on Twitter

Open Heart ·
@Open_HeartBMJ

Ischemic #HeartDisease (IHD) is the No. 1 cause of death, disability, and human suffering globally.

@BMJBestPractice is offering a free 7 day trial to access information on over 100 topics - including IHD.

https://t.co/RL7zZKZWaj https://t.co/EhZCMOyPBW

View on Twitter

Open Heart ·
@Open_HeartBMJ

Prevalence of cardiac pathology & relation to mortality in a multiethnic population hospitalised with #COVID19

It is more about RV or LV dysfunction?

#OpenHeartBMJ @supportcardiac @emmaukresearch @talentedmrsO
https://t.co/aPeUzYYS1B https://t.co/N6GxXOh4yi

View on Twitter

Intro Pullout Text Widget

Open Heart

Authors

Latest Articles

Coronary artery disease:

Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay

Viewpoint:

FLOWER-MI and the root of the problem with non-culprit revascularisation

Aortic and vascular disease:

Myocardial infarction coincides with increased NOX2 and Nε-(carboxymethyl) lysine expression in the cerebral microvasculature

Arrhythmias and sudden death:

Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience

Cardiac risk factors and prevention:

CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation

FREE: Latest COVID-19 Content

HEALTH CARE DELIVERY, ECONOMICS AND GLOBAL HEALTH CARE:

OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic

SPECIAL POPULATIONS:

Prevalence of cardiac pathology and relation to mortality in a multiethnic population hospitalised with COVID-19

SPECIAL POPULATIONS:

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

SPECIAL POPULATIONS:

Echocardiography in suspected coronavirus infection: indications, limitations and impact on clinical management

HEALTH CARE DELIVERY, ECONOMICS AND GLOBAL HEALTH CARE:

Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

Most Read Articles

Editorial:

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

Editorial:

Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections

Cardiac risk factors and prevention:

Using genetics to detangle the relationships between red cell distribution width and cardiovascular diseases: a unique role for body mass index

Special populations:

Normative blood pressure response to exercise stress testing in children and adolescents

Viewpoint:

Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction

Twitter Feed